Summary of Study ST003766

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002349. The data can be accessed directly via it's Project DOI: 10.21228/M80N9V This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003766
Study TitleHepatic bioenergetics and metabolism in mitochondrial disease: Insights from the Ndufs4 KO mouse model
Study TypeMulti-platform metabolomics analysis
Study SummaryMitochondrial diseases, including Leigh syndrome, frequently result from complex I (CI) deficiencies and lack effective treatments. Investigating metabolic alterations in affected tissues is essential to understanding disease progression and identifying therapeutic targets. The aim of this project was to characterize the metabolic profile of Ndufs4 knockout (KO) mouse livers, a model of CI deficiency, using multi-platform metabolomics. Whole-liver extracts from Ndufs4 KO and wild-type mice were analyzed via untargeted GC-TOFMS and semi-targeted LC-MS/MS. Metabolic profiling revealed widespread disruptions, including altered glucose, amino acid, and nucleotide metabolism, as well as TCA cycle intermediates. Key findings included elevated levels of UDP-glucose and UDP-N-acetylglucosamine, indicating shifts toward anabolic pathways such as hexosamine biosynthesis and glycogen synthesis. These data highlight the potential role of metabolic reprogramming in liver adaptation to mitochondrial dysfunction and provide new directions for investigating interorgan metabolic dynamics in mitochondrial diseases.
Institute
North-West University
DepartmentBiochemistry
LaboratoryMitochondria Research Group
Last NameLouw
First NameRoan
AddressHoffman Street, Potchefstroom, North-West, 2520, South Africa
EmailRoan.Louw@nwu.ac.za
Phone+27 18 299 4074
Submit Date2024-12-02
Raw Data AvailableYes
Raw Data File Type(s)smp, d
Analysis Type DetailGC-MS/LC-MS
Release Date2025-12-02
Release Version1
Roan Louw Roan Louw
https://dx.doi.org/10.21228/M80N9V
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN006181 AN006182
Chromatography ID CH004692 CH004693
MS ID MS005885 MS005886
Analysis type MS MS
Chromatography type Reversed phase GC
Chromatography system Agilent 1260 infinity Agilent 7890A
Column Agilent ZORBAX RRHT StableBond Aq (100 x 2.1mm, 1.8um) Restek Rxi-5MS (28.6m x 0.25mm,0.25um)
MS Type ESI EI
MS instrument type Triple quadrupole GC-TOF
MS instrument name Agilent 6470 Leco Pegasus HT TOF
Ion Mode POSITIVE POSITIVE
Units Normalised peak areas

Chromatography:

Chromatography ID:CH004692
Chromatography Summary:ZORBAX RRHT StableBond Aq Column (Part Number:828700-914)
Instrument Name:Agilent 1260 infinity
Column Name:Agilent ZORBAX RRHT StableBond Aq (100 x 2.1mm, 1.8um)
Column Temperature:45
Flow Gradient:95 % of solvent A held for 0.2 min, increased to 25 % of solvent B over 1.8 min, held for 5 min, increased to 90 % of solvent B over 0.5 min, held for 1.6 min, increased to 95 % of solvent B over 2.9 min, decreased to 5 % of solvent B over 1 min, and re-equilibrated for 3 min to give a total run time of 16 min.
Flow Rate:For the first 9 min of the run, the mobile phase flow rate was set at 0.3 mL/min, after which it was increased to 0.4 mL/min in a span of 0.1 min and maintained at this level for the subsequent 3.9 min of the run
Sample Injection:One microliter of each sample was injected
Solvent A:100% water; 0.1 % formic acid
Solvent B:100% acetonitrile; 0.1 % formic acid
Chromatography Type:Reversed phase
  
Chromatography ID:CH004693
Instrument Name:Agilent 7890A
Column Name:Restek Rxi-5MS (28.6m x 0.25mm,0.25um)
Column Temperature:70°C for 1 min, 7°C/min minute increase until 120°C, 10°C/min increase until 230°C, 13°C/min increase until 300°C, held for 1 min
Flow Gradient:-
Flow Rate:-
Solvent A:-
Solvent B:-
Chromatography Type:GC
  logo